Inflammation

Items 1071-1080 of 1366

per page
Set Descending Direction
  1. CD86 (human):Fc (mouse) (rec.)
    CHI-HF-211CD86
    CHI-HF-211CD86-C100100 µg
    CHF 430.00
  2. CD86 (P2) (human)-muIg Fusion Protein (Biotin)
    ANC-579-030.
    ANC-579-03025 µg
    CHF 669.00
  3. cGAS (human) (rec.) (His) (Active) (100µg)
    BBL-2228
    BBL-2228-C100100 µg
    CHF 1'808.00
    cGAS (human) (rec.) (His) (Active) (100µg)
  4. cGAS Monoclonal Antibody (Clone 5G10)
    CAY-23853
    CAY-23853-300300 µg
    CHF 776.00
  5. Citrullinated LL-37 Monoclonal Antibody (Clone 6A8)
    CAY-26739
    CAY-26739-300300 µg
    CHF 561.00
  6. Clusterin (nuclear form) (human) (rec.) (His)
    AG-40A-0047
    AG-40A-0047-C05050 µg
    CHF 380.00
  7. Clusterin (secretory form) (human) (rec.)
    AG-40A-0050Y
    AG-40A-0050Y-C01010 µg
    CHF 190.00
    AG-40A-0050Y-C05050 µg
    CHF 380.00
    After denaturation of recombinant secretory clusterin in the presense of β-mercaptoethanol followed by boiling, two distinct bands, 60kDa and 35kDa, were seperated on SDS-PAGE. The two bands were extracted and subjected to determination of their N-te
  8. Cochlin (human) (LCCL domain) (rec.)
    AG-40B-0135
    AG-40B-0135-C01010 µg
    CHF 360.00
    AG-40B-0135-30103 x 10 µg
    CHF 720.00
  9. Contactin-6 (human):Fc (human) (rec.)
    AG-40A-0156
    AG-40A-0156-C01010 µg
    CHF 215.00
    AG-40A-0156-C05050 µg
    CHF 540.00
    Induction of Hes-1 with the treatment of hContactin-6-Fc.
A mouse preadpipocyte cell line, 3T3L1, was stimulated with 5μg/ml of hContactin-6-Fc (Prod. No. AG-40A-0156) as in indicated time points and each cell lysate was prepared and subjected to
  10. CTRL2-ODN (Control for iODN and CpG-ODNs) Endotoxin-free (sterile)
    IAX-200-208
    IAX-200-208-C100100 µg
    CHF 153.00
    IAX-200-208-M0011 mg
    CHF 449.00
    CTRL2-ODN (Control for iODN and CpG-ODNs) Endotoxin-free (sterile)

Items 1071-1080 of 1366

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.